Respiratory distress syndrome (RDS) is a condition primarily affecting premature infants, characterized by insufficient surfactant production leading to alveolar collapse and impaired gas exchange. Early intervention with surfactant replacement therapy and supportive care can significantly improve outcomes and reduce mortality rates in affected neonates.